| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |